Jonathan Lim, M.D. retweeted
At #SITC2017? See our poster on TYRO3/AXL/MER (TAM) as a novel #immunooncology target in #cancer 12:30pm & 6:30pm ET https://teapawt.net/t.co/OYgiOjNI7Y
Jonathan Lim, M.D. retweeted
Good news for NTRK+ NSCLC patients. We must search this oncogenic fussion and include it into the screening panels
Jonathan Lim, M.D. retweeted
Lost our amazing 27 yr old daughter to #lungcancer this year. Can't imagine 433 families a day dealing with the pain of this loss #433aday
Jonathan Lim, M.D. retweeted
I think this is the best headline we have ever had about our work on systems innovation in health care. news.harvard.edu/gazette/sto…
Jonathan Lim, M.D. retweeted
Brain metastases occur in 20-40% of all patient with cancer. CNS-active treatments are urgently needed. #WCLC2017
Jonathan Lim, M.D. retweeted
ROS1 spotlight: #DYK ROS1 gene fusions are associated with #NSCLC & other #cancers? #PrecisionMedicine #WCLC2017
Jonathan Lim, M.D. retweeted
Very important observation that BRAF follows EGFR and ALK in being less responsive to immunotherapy despite higher smoker status teapawt.net/rdoebele/status/919757…
Jonathan Lim, M.D. retweeted
#CancerMoonshot calls for #clincialtrial designs that highlight patient engagement & improve #PrecisionMedicine https://teapawt.net/t.co/ObZfgfmmYM
Jonathan Lim, M.D. retweeted
It's #LungCancer Awareness Month! Check out @LUNGevity's chart on #NSCLC driver mutations, many of which are targeted by our pipeline. #LCAM
Jonathan Lim, M.D. retweeted
Watch: @VP Biden on the #CancerMoonshot initiative and the steps we're taking to put an end to cancer as we know it: go.wh.gov/gLjsES
Jonathan Lim, M.D. retweeted
Brakes truly off for checkpoint inhibitors in NSCLC! Pembrolizumab now FDA approved firstline standard of care. reut.rs/2f3ZstR
Jonathan Lim, M.D. retweeted
Thanks to @BVBigelow from @Xconomy for visiting @Ignyta a few weeks ago. Check out his story about our science here: https://teapawt.net/t.co/oHNpTV6gsB
Jonathan Lim, M.D. retweeted
"I must confess I’m a science geek. I’m a nerd. I won’t make any apologies for it" —@POTUS speaking at #WHFrontiers: frontiersconference.org
Jonathan Lim, M.D. retweeted
October is #BreastCancerAwarenessMonth! Check out @TIME to learn about the genetic drivers of #breastcancer ti.me/2dADydS #BCAM
Jonathan Lim, M.D. retweeted
ESMO 2016 Press Release: Single-Arm Trials Improve Early Access to Rare Cancer Drugs | ESMO esmo.org/Conferences/ESMO-20…
Jonathan Lim, M.D. retweeted
Original Article: Pembrolizumab or Chemotherapy in PD-L1–Positive Non–Small-Cell Lung Cancer (KEYNOTE-024) nej.md/2deKOuj #ESMO16
Jonathan Lim, M.D. retweeted
For those starting biotechs, this 2013 blog remains very relevant. Foundings Matter: Thiel’s Law Applied To Biotech lifescivc.com/2013/06/foundi…


















